Levetiracetam in the Treatment of Idiopathic Hemifacial Spasm
Neurol 62:2134-2135, Deleu,D., 2004
Botulinum Toxin A Treatment for Primary Hemifacial Spasm
Arch Neurol 59:418-420, Defazio,G.,et al, 2002
Uses of Botulinum Toxin Injection in Medicine Today
BMJ 320:161-165, Munchau,A. & Bhatia,K.P., 2000
Long Term Results of Botulinum Toxin Type A (Dysport) in the Treatment of Hemifacial Spasm:A Report of 175 Cases
JNNP 64:751-757, Jitpimolmard,S.,et al, 1998
Hemifacial Spasm:Clinical Findings and Treatment
Muscle & Nerve 21:1740-1747, Wang,A & Jankovic,J, 1998
The Relationship of Essential Tremor to Other Movement Disorders:Report on 678 Patients
Ann Neurol 35, 717-7231994., Koller,W.C.,et al, 1994
Botulinum Toxin, Useful in Adult Onset Focal Dystonias
BMJ 305:1169-1170, Lees,A.J., 1992
Treatment of Hemifacial Spasm with Botulinum Toxin
Muscle & Nerve 15:1045-1049992., Yoshimura,D.M.,et al, 1992
Essential Tremor:Clinical Correlates in 350 Patients
Neurol 41:234-238, Lou,J.&Jankovic,J., 1991
Therapeutic Uses Of Botulinum Toxin
NEJM 324:1186-1194, Jankovic,J.&Brin,M.F., 1991
Clinical Use of Botulinum Toxin
National Institutes of Health Consensus Develop Conf Stmt, Nov 12-14, 1990, Arch Neurol 48:1294-1298, 199, 1991
Botulinum Toxin Treatment of Cranial-Cervical Dystonia, Spasmodic Dystonia, Focal Dystonias & Hemifacial Spasm
JNNP 53:633-639, Jankovic,J.,et al, 1990
Assessment:The Clinical Usefulness of Botulinum Toxin-A in Treating Neurologic Disorders
Subcommittee Report, Neurol 40:1332-13361990., , 1990
Hemifacial Spasm in Rochester & Olmsten County, Minnesota, 1960-21984
Arch Neurol 47:1233-1234, Auger,R.G.&Whisnant,J.P., 1990
Blepharospasm, Meige Syndrome, & Hemifacial Spasm:Treatment with Botulinum Toxin
Neurol 35:1499-1500, Mauriello,J.A., 1985
Pathophysiology of Hemifacial Spasm:III, Effects of Facial Nerve Decompression
Neurol 34:891-897, Nielsen,V.K.,et al, 1984
Carbamazepine for Hemifacial Spasm
Neurol 32:286-287, Alexander,G.E.,et al, 1982
Hemifacial Spasm; A Long Term Follow-up of Patients Treated by Posterior Fossa Surgery & Facial Nerve Wrapping
JNNP 44:1100-1103, Kaye,A.H.,et al, 1981
Neurologic Disturbances in Pagets Disease of Bone:Response to Calcitonin
Neurol 29:448-457, Chen,J.R.,et al, 1979
Hemifacial Spasm
Arch Neurol 35:481, Maroon,J.C., 1978
Infantile Epileptic Spasms Syndrome (West Syndrome)
Stat Pearls PMID:30725936, Smith,M.S.,et al, 2025
Clinicopathological Conference, Glutamic Acid Decarborylase 65 Autoantibody-Associated Stiff-Person Syndrome
NEJM 390:1712-1719, Case 14-2024, 2024
Clinicopathologic Conference, Reversible Cerebral Vasoconstriction Syndrome with Takotsubo Cardiomyopathy
NEJM 390:2108-2118, Case 18-2024, 2024
Clinicopathologic Conference, Hypocalcemic Myopathy Due to Hypoparathyroidism
NEJM 388:1513-1520, Case 12-2023, 2023
Spontaneous Subarachnoid Haemorrhage
Lancet 400:846-862, Claassen, J. & Park, S., 2022
Automated Brain Perfusion Imaging in Acute Ischemic Stroke: Interpretation Pearls and Pitfalls
Stroke 52:3728-3738, Nicolas-Jilwan, M. & Wintermark, M., 2021
Clinicopathologic Conference, Moyamoya Disease
NEJM 385:2563-2572, Case 40-2021, 2021
Intra-Arterial Verapamil Treatment in Oral Therapy - Refractory Reversible Cerebral Vasoconstriction Syndrome
AJNR 41:293-299, Ospel, J.M.,et al, 2020
Clinicopathologic conference, Vitamin D deficiency
NEJM 383:2462-2470, Case 39-2020, 2020
Treatment of Tics in People with Tourette Syndrome and Chronic Tic Disorders
Neurol 92:896-906, Pringsheim, T.,et al, 2019
Recurrent Involuntary Contractions of the Face, Arm, and Leg in an Elderly Man
JAMA Neurol 76:728-729, Kim, D.D.,et al, 2019
Reversible Cerebral Vasoconstriciton Syndrome
www.UptoDate.com, June, Singhal, A., 2019
Tics and Functional Tic-Like Movements
Neurol 93:750-758, Ganos, C.,et al, 2019
Anti-LG11 Limbic Encephalitis Presenting as an Expanding Insular Lesion
Can J Neuro Sci 46:770-772, Sitwell,L.D.,et al, 2019
Efficacy of Botulinum Toxin A for Treating Cramps in Diabetic Neuropathy
Ann Neurol 84:682-690, Restivo, D.A.,et al, 2018
Morvan Syndrome as a Paraneoplastic Disorder of Thymoma with Anti-CASPR2 antibodies
Lancet 389:1367-1368, Vale, T.C.,et al, 2017
Subarachnoid Hemorrhage
NEJM 377:257-266, Lawton, M.T. & Vates, G.E., 2017
An 82-year-old man with Worsening Gait
Neurol 89:e246-e252, Chew, S.,et al, 2017
Diagnosis and Treatment of Tourette Syndrome
Neurol 87:e65-e67, Hirschtritt, M.E.,et al, 2016
Reversible Cerebral Vasoconstriction Syndrome, Part 1: Epidemiology, Pathogenesis, and Clinical Course
AJNR 36:1392-1399, Miller, T.R.,et al, 2015
Systematic Review: Efficacy and Safety of Medical Marijuana in Selected Neurologic Disorders
Neurol 82:1556-1563, Koppel, B.S.,et al, 2014
Inherited Metabolic Diseases of the Nervous System, Globoid Cell Leukodystrophy (Krabbe Disease, Galactocerebrosidase)
Adams & Victors Principles of Neurology, Chp 37, pg 959, Ropper, A.H.,et al, 2014
Degenerative Diseases of the Nervous System, Amyotrophic Lateral Sclerosis
Adams & Victors Principles of Neurology, Chp 39, pg 1109, Ropper, A.H.,et al, 2014
Polymyalgia Rheumatica
Lancet 381:63-72, Kermani, T. & Washington, K., 2013
Tourettes Syndrome
BMJ 347:f4964, Cavanna, A.E. & Seri, S., 2013
Clincopathologic Conference,Graves Disease with Thyrotoxic Periodic Paralysis
NEJM 366:553-560, Case 4-2012, 2012
Evidence-based Guideline Update: Medical Treatment of Infantile Spasms
Neurol 78:1974-1980, Go, C.Y.,et al, 2012
Heterogeneity of Coenzyme Q10 Deficiency
Arch Neurol 69:978-983, Emmanuele, V.,et al, 2012
Adult Primary Central Nervous System Vasculitis
Lancet 380:767-777, Salvarani, C.,et al, 2012